Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 September 2023: Clinical Research

Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II–III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy

Radu Valeriu Toma 12ABCG , Zgura Anca 1E , Oana Gabriela Trifănescu 12A , Laurenţia Nicoleta Galeş 12D* , Antonia Ruxandra Folea 2CDEF , Loredana Stanca 3B , Liviu Bîlteanu 234ABCDEF* , Rodica M. Anghel 1A

DOI: 10.12659/MSM.941754

Med Sci Monit 2023; 29:e941754

Supplementary Table 12 Parameter estimates of in multinomial logistic models including the predictors in Figure 3 in the manuscript for EF drop continuation after CHT.

BStd. errorWalddfSig.Exp(B)95% confidence interval for Exp(B)
Lower boundUpper bound
Model 1Intercept−5.6222.1766.6751.010
[Pre-existing] cardiac diseases3.0831.3405.2931.02121.8161.578301.536
LAD Mean Dose ≥32.7 Gy2.6571.2944.2121.04014.2481.127180.107
Model 2Intercept−4.8301.5409.8381.002
[Pre-existing] cardiac diseases3.0611.0069.2551.00221.3462.971153.369
Cycle 3 dose ≥160 mg/m2.144.8915.7841.0168.5331.48748.966

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750